Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024. In the quarter to June 2026, revenue grew 38.3%, EPS fell 294.7%, free cash flow grew 5.09% and total debt rose 40.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

28.07 1.31 −4.46%
Market cap
$6.9B
P/E
0.0×
Fwd P/E
−213×
Dividend yield
—
F-score
4/9
Altman Z
4.10
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '19 Jan '20 Dec '20 Jan '21 Dec '21 Jan '22 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
1.66 — 113.08 — 269.91 — 216.60 265.05 395.83 767.64
Total non-current assets
203.11 — 5.61 — 150.68 — 149.75 176.13 311.71 1,387.07
Total Assets
204.77 — 118.70 — 420.59 — 366.34 441.19 707.54 2,154.71
Total current liabilities
0.98 — 15.23 — 79.22 — 47.94 88.47 221.37 404.43
Total non-current liabilities
198.79 — 250.34 — 6.75 — 6.66 8.69 9.46 1,209.35
Total liabilities
199.77 — 265.57 — 85.97 — 54.60 97.16 230.82 1,613.78
Common Equity (Total)
5.00 — (146.87) — 334.62 — 311.74 344.03 476.72 540.93
Shareholders Equity (Total)
5.00 — (146.87) — 334.62 — 311.74 344.03 476.72 540.93
Total Debt
— — — 4.12 — 3.65 — — — 972.58

Show all line items

In millions of $ except per-share values · columns are period end dates